Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
InMed Pharmaceuticals Inc. (INM)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues |
| BayMedica | 2.3 | 1.0 | 0.3 | 0.5 | 0.3 | 0.3 | | |
| |
| EBIT |
| BayMedica | 0.9 | -0.4 | -1.2 | -3.9 | -0.5 | 0.9 | | |
| InMed | -1.2 | -1.6 | -2.3 | -3.9 | -2.9 | -3.6 | -3.0 | -3.3 |
| |
| Mix |
| BayMedica | 62.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| |
| Growth |
| BayMedica | 349.0% | 234.0% | | | | | | |
|